---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-22-000062"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T12:00:38.671751+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints Marlene McLennan as interim CFO effective Dec 1, 2022

## Summary
- Marlene McLennan appointed interim CFO, effective December 1, 2022; prior CFO at Vestige Healthcare and other healthcare firms.
- Annual base salary of $350,400; eligible for bonus up to 50% of base subject to board approval.
- Stock option grants of 25,000 shares per 6-month term under 2019 Stock Incentive Plan.
- Severance lump sum of $60,000 if terminated without cause or non-renewal, subject to performance criteria.
- Employment agreement initial 6-month term, renewable up to 18 months total.

## SEC filing metadata
- accession: 0000926617-22-000062
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/0000926617-22-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/awh-20221128x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-22-000062
- JSON: https://secwatch.observer/filing/0000926617-22-000062.json
- Plain text: https://secwatch.observer/filing/0000926617-22-000062.txt

## Key facts
- Executive change
  Marlene McLennan was appointed as interim Chief Financial Officer at Aspira Women's Health Inc..
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Marlene McLennan as the Company’s interim Chief Financial Officer, effective as of December 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/0000926617-22-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.